Cargando…
Prevalence and Risk Factors of Germline Pathogenic Variants in Pancreatic Ductal Adenocarcinoma
PURPOSE: The genetic attribution for pancreatic ductal adenocarcinoma (PDAC) has been reported as 5%–10%. However, the incidence of germline pathogenic variants (PVs) in Korean PDAC patients has not been thoroughly investigated. Therefore, we studied to identify the risk factors and prevalence of PV...
Autores principales: | Ryu, Kum Hei, Park, Sunhwa, Chun, Jung Won, Cho, Eunhae, Choi, Jongmun, Lee, Dong-Eun, Shim, Hyoeun, Kim, Yun-Hee, Han, Sung-Sik, Park, Sang-Jae, Woo, Sang Myung, Kong, Sun-Young |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Cancer Association
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10582541/ https://www.ncbi.nlm.nih.gov/pubmed/37024097 http://dx.doi.org/10.4143/crt.2023.291 |
Ejemplares similares
-
Genetic assessment of pathogenic germline alterations in lysosomal genes among Asian patients with pancreatic ductal adenocarcinoma
por: Koh, Youngil, et al.
Publicado: (2023) -
Diagnostic rate of germline pathogenic variants in pancreatic ductal adenocarcinoma patients using whole genome sequencing
por: Chung, An-Ko, et al.
Publicado: (2023) -
BRCA 1/2 Germline Mutation Predicts the Treatment Response of FOLFIRINOX with Pancreatic Ductal Adenocarcinoma in Korean Patients
por: Park, Ji Hoon, et al.
Publicado: (2022) -
Overall survival of pancreatic ductal adenocarcinoma is doubled by Aldh7a1 deletion in the KPC mouse
por: Lee, Jae-Seon, et al.
Publicado: (2021) -
Prognostic Value of VEGF in Human Pancreatic Ductal Adenocarcinoma
por: Lim, Yun Jeong, et al.
Publicado: (2004)